Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-23

FDA Approved: BRIMONIDINE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved Padagis Israel Pharmaceuticals Ltd's original application for Brimonidine, a generic ophthalmic solution, for lowering elevated intraocular pressur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine (brimonidine)

Snippet

ORIG AP for BRIMONIDINE (BRIMONIDINE)